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Abstract The potential role of alkylresorcinol compound from whole grains for prevention and inhibition
of human cancer cell lines has been reported in observational and in vitro studies. The objective of this study
was to present an updated review on the association
between alkylresorcinols and cancer risk and aspects of
their bioactivity with implications for carcinogenesis.
Relevant studies were identified by searching PubMed,
Scopus, ProQuest, EBSCOhost, SpringerLink, ArticleFirst, Taylor & Francis, Wiley Online, and ScienceDirect electronic databases using these search terms and
key words: alkylresorcinols, cancer, carcinoma, risk.
Furthermore, references from retrieved articles were
also reviewed. Four observational and 10 in vitro studies were included in the analysis of natural or synthetic
alkylresorcinols for anticancer activities. Two prospective studies reported a 52–66% risk reduction of distal
colon cancer at nanomolar alkylresorcinols concentration in plasma; the remaining studies found no reduction of endometrial cancer risk and an approximate 40%
increase in prostate cancer risk. In vitro studies presented inhibition of human colon, breast, lung, central
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nervous system, adenocarcinoma, hepatocarcinoma, cervix squamous carcinoma, and ovarian cancer cell lines,
at micromolar alkylresorcinols concentration. Evidence
from prospective studies confirmed significant inverse
associations between whole grains intake and distal
colon cancer risk. Model studies suggest a high cytotoxicity of alkylresorcinols toward cancer cells. These
findings maintain that alkylresorcinols as components
of whole grains are likely to find application in cancer
prevention; however, the need for intervention studies to
confirm their preventive action is warranted.
Keywords Alkylresorcinols · Bioactivity · Cancer ·
Prevention · Cytotoxicity
Abbreviations
ARs	Alkylresorcinols
ROS	Reactive oxygen species
IGF	Insulin growth factor
LDL	Low-density lipoprotein
ROO·	Peroxyl radical
FFQ	Food frequency questionnaire
IC50	Inhibitory concentration–inhibit cellular proliferation by 50%
PSA	Prostate specific antigen
OR	Odds ratio
IRR	Incidence rate ratio
CI	Confidence interval
TGI	
Concentration of drugs that totally inhibit cell
growth
LC50	Concentration of drugs resulting in cell death to
50%
5-AR	5-Alkylresorcinol
DNA	Deoxyribonucleic acid
ATP	Adenosine triphosphate
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Introduction
There are several environmental factors that influence
cancer development. Studies demonstrate an independent effect of dietary patterns on cancer risk which are
modifiable by diet. Evidence suggests that diet represents
30–35% of all risk factors contributing to the onset of
cancer. Positive health effects have been reported for vegetables, fruits, and whole grains [1–6]. Whole grain foods,
rich in dietary fiber, minerals, vitamins, and phytochemicals, are recognized as agents exerting health protective
effects [7]. Much of the research on relationships between
diet and cancer risk is based on the hypothesis that high
intake of these nutrients rich in antioxidants (e.g., polyphenolic compounds, lignans, vitamins) may affect a number
of physiological and pathological processes, like signaling
mediated by MAP-kinases, insulin growth factor (IGF-1),
nuclear transcription factor (NF-κβ), cytochrome P450, and
reactive oxygen species (ROS) [8, 9]. Transformation of
healthy cells and tumorigenesis can be linked to increased
DNA mutagenesis, decreased apoptosis, increased cell proliferation, inflammation, and several other processes controlled by antioxidants, thus antioxidants can prevent DNA
damage and potentially protect against cancer [10–13].
Nonetheless, the scientific evidence on diet–cancer risk

Fig. 1  General structure and
common dietary sources of
alkylresorcinols (R = n-alkyl or
n-alkenyl chain)
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interactions is not conclusive [5, 14]. Over the last two
decades, research interest in medicine and functional food
production in the application of whole grains and dietary
phytoestrogens has increased significantly [1, 15]. Of particular interest in relation to tumorigenesis is the class of
natural compounds, like phenolic lipids also known as
alkylresorcinols (ARs) (Fig. 1).
A wide range of biological properties of ARs, including antimicrobial [16], antimutagenic [17], and antioxidant potency have been reported [7, 18]. Epidemiologic
evidence demonstrates that consumption of whole grain
cereals is associated with positive health benefits such as
decreased risk of overweight and obesity, coronary heart
disease, diabetes, and some types of cancer [19–24]. There
is insufficient evidence to support the association of ARs
with decreased risk of cancer because whole grains beside
phenolic lipids contain a high number of primary metabolites (e.g., fiber, sulfur amino acids, lignin, oligosaccharides, minerals, vitamins), polyphenols (e.g., phenolic
acids, flavonoids, lignans), phytosterols, melatonin, and
other bioactive compounds [7, 15, 21, 25]. In addition,
each of these compounds exhibits biological actions which
are frequently reported in the literature as health protective mechanisms. In view of these facts, the main objective
of this review article is to evaluate and present the current
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evidence related to ARs and cancer risk and some aspects
of the AR’s biological activities related to carcinogenesis.
Occurrence, pharmacokinetics, extraction, and analysis of
ARs will be also presented briefly.

objectives and scope. All retrieved titles, abstracts, and
full-text publications were reviewed and screened for
relevance to the topic. Furthermore, references from
retrieved articles were reviewed to identify additional
applicable publications.

Methods
Inclusion/exclusion criteria
An integrative review of the literature was carried out
prior to January 2017. Relevant articles were identified
by applying search strategies to nine academic electronic databases: PubMed, Scopus, ProQuest, EBSCOhost, SpringerLink, ArticleFirst, Taylor & Francis,
Wiley Online, and ScienceDirect. Search terms and key
words included: Alkylresorcinols; cancer; carcinoma;
risk. These databases were chosen due to their extensive
coverage of biomedical and cross-disciplinary research

SCREENING & ELIGIBILITY

IDENTIFICATION

Fig. 2  Flow diagram of literature search process

Inclusion criteria for refereed study samples included
observational and in vitro studies. Other article types
such as conference abstracts, communications, commentaries, editorials, brief reports, position, and hypothesisgenerating statements were excluded. Gray literature and
non-refereed publications were also excluded. No language restrictions were imposed. A flowchart of the study
screening and selection is presented in Fig. 2.

538 total citations identified
from database search resultsPubMed: 22
Scopus: 24
ScienceDirect: 204
EBSCOhost: 173
SpringerLink: 26
Taylor & Francis Online: 17
Wiley Online: 37
ArticleFirst: 3
ProQuest: 32

404 citations excluded after
abstract screening and
duplicates removed (n=134)

110 citations excluded after
full -text screening for
relevance (n=24)

INCLUDED

2 citations added after
checking reference lists

Eligible citations passed fulltext screening and inclusion
criteria (n=26)
PubMed: 2
Scopus: 19
ScienceDirect: 4
Wiley Online: 1
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Results

Alkylresorcinols during grain processing

Prevalence of alkylresorcinols

In contrast to whole grain foods, refined products contain
only trace-concentrations of AR [15]. Grain processing
(e.g., milling, cooking, fermentation) changes the nutritional content of cereal grains by fragmentation of the grain
matrix and gelatinization of starch granules [7, 43]. Due to
occurrence of ARs, vitamins, minerals and trace elements,
and antioxidants in the outer parts of the grain, the final
nutrient content will be dependent on the extent to which
the outer parts are removed during processing. For example, refining whole grain wheat may result in the loss of
about 58% of fiber, 79% of zinc, 79% of vitamin E, 83%
of magnesium, and 92% of selenium [7]. High-temperature
processing of cereal grains decreases AR content in grain
food due to denaturation and degradation [15].

This large group of phenolic compounds (1,3-dihydroxy-5-n-alkylbenzenes) (about 150 natural occurring
ARs) [26] consists of a single phenolic ring with two
hydroxyl groups (OH) in the meta-position and odd numbered alkyl side chain (R) which can contain between
13 and 27 carbon atoms with dominance in the range
of C15–C25 at position 5C in the benzene ring [27].
The hydrocarbon chains can contain two double bonds
between carbon atoms, ketone, or hydroxyl groups. The
chemical structure and length of chains depend on biological origin [28]. The following five major classes of
ARs have been reported in whole grain, wheat, and rye:
5-n-alkylresorcinols, 5-alkenylresorcinols, 5-oxoalkylresorcinols, 5-oxoalkenylresorcinols, and 5-hydroxyalkenylresorcinols [15]. Alkenylresorcinols, the phenolic lipids
with unsaturated hydrocarbon side chains, accounted for
about 20% of the total amount of ARs as were identified
and quantified by Söderholm et al. in rye bread [29].
These compounds are present in several plant families and some bacteria, fungi, algae, and marine sponges
[27]. Among food plants, ARs occur in the whole grain
or bran fractions; they are distributed in the outer cuticula of the testa and inner cuticula of the pericarp in rye,
wheat grains, and in smaller amounts in barley. Various
cereal grains are grown in different countries, depending on climatic conditions. In the regions with cold temperature and poor quality soils, rye is an important cereal
grain, although cultivation of rye constitutes just 3% of
the worlds wheat production. The AR content, its chemical structure, and the homologue ratios differ between
cereal grains and are dependent on several environmental
factors like geographical region, soil composition, fertilization, and cultivation [30–32]. ARs occur mainly in the
outer parts of whole wheat and rye products at high concentrations (200–4000 µg per gram of dry matter) and at
low concentration in refined flour or products (40–280 µg
per gram of dry matter) [33–35]. ARs are proposed as
valid biomarkers of whole grain and rye consumption of
cereal grains which are the main human food crop [30,
36–39]. The ARs concentration is dependent on grain
type. For example, rye contains about 797–1231 µg/g of
dry matter, wheat 220–650 µg/g of dry matter, and barley 40–110 µg/g of dry matter [40]. A relative high concentration (489–1429 µg/g of dry matter) of ARs occurs
in wheat bran [15] of which human consumption has
increased over the years [41]. Among cereal grains such
as rye, wheat, and durum wheat, rye is richest in ARs
[42].
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Anti‑nutrients in grain cereals
Notably, whole grain cereals also contain anti-nutrients
which exert both adverse and positive health effects [7,
44–46]. Anti-nutritional factors can reduce nutrient intake,
design, absorption, and utilization. The factors are naturally present in grains or they originate from contamination
(fungal origin, related to soil and other environmental influences). The most important are phytic acid, lectins, tannins, saponins, inhibitors of proteases, and amylases which
modify the nutritional values of cereals. For example, tannins and the phosphorus compound phytic acid can bind
iron, calcium, and zinc; lectins can damage the intestinal
microvilli and interact with antibodies, thus stimulating an
immune system response. There is significant interest in
understanding how processing influences concentrations of
bioactive phytochemicals present in whole rye, wheat, and
barley from different cultivations and in obtaining functional ingredients rich in ARs [34, 47]. Therefore, several
reduction strategies have been developed to reduce antinutrients and improve whole grain foods. For example,
processing of cereal grains through cooking, roasting, fermentation, and germination may decrease concentration of
tannins and phytic acid [3, 7].
Pharmacokinetics of alkylresorcinols
According to a scheme proposed by Landberg et al. [48],
presenting the pathways of AR absorption, distribution,
metabolism, and excretion, the compounds are absorbed
in the small intestine, although there is no clear evidence
describing the mechanism of absorption. The authors suggested that in the intestinal cells ARs can be assembled
into chylomicrons, followed by their transportation into the
lymphatic system. The compounds may also be absorbed
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directly during transfer to HDL (high-density lipoprotein), LDL (low-density lipoprotein), and VLDL (very
low-density lipoprotein) fractions. Next, from lipoproteins
ARs are distributed into erythrocyte membranes, wherein
the plasma-erythrocyte ratio is dependent on the chain
length ranging from 0.5 to 1.3, being higher for longer
homologues. An analysis of AR level in erythrocytes and
in plasma showed that their concentration was maximal
after about 13 h post-feeding (300–500 nM) and at 7 h
(3365 nM), respectively when ARs are consumed several
times daily. The ARs absorption level and elimination halftime, the time at which the excretion rate decreases to half
of the maximal excretion rate in humans and animals, are
the individual features changing at different value ranges
between individuals [26]. Similar to tocopherols, ARs are
eliminated from circulation with an apparent half-life about
of 5 h [48]. These findings, as well as studies on metabolism of resorcinols and 4-n-nonylphenyl, propose similar
metabolism of ARs as tocopherols including two phases.
In phase I, ARs are metabolized by the introduction of a
hydroxyl group (HO) at the end of the alkyl tail through
omega-oxidation catalyzed by cytochrome P450 isoenzyme
CYP4F2. Next, the HO group is oxidized to a carboxylic
acid, followed by successive β-oxidation, thus making the
alkyl chain shorted, and two main water-soluble metabolites: 3-(3,5-dihydroxyphenyl)-1-propanoic acid (DHPPA)
and 3,5-dihydroxybenzoic acid (DHBA) are final products
of this phase [42–48]. In phase II, ARs and their intermediate and final metabolites are partially conjugated by a
polar group to xenobiotics or endogenous compounds.
Conjugation with glucuronide sulfate groups and amino
acids is the key reaction improving urinary excretion of AR
metabolites. Two AR metabolites DHPPA and DHBA were
detected in plasma and human urine [29, 49, 50] and considered as biomarkers of whole grain wheat and rye intake.
For example, Söderholm et al. observed maximum exertion rates of 5–6 h for DHPPA and DHBA metabolites, and
significant amounts were still measurable at 25 h in human
urine [29]. Recently, new ARs metabolites 3,5-dihydroxycinnamic acid (DHCA), 5-(3,5-dihydroxyphenyl) pentanoic acid (DHPPTA), 3,5-dihydroxycinnamic acid amide
(DHCA-amide), and 2-(3,5-dihydroxybenzamido)acetatic
acid (DHBA-glycine) were developed in human urine
samples [51, 52]. Although their concentrations in urine
were considerably lower than those of DHPA and DHPPA
metabolites [52], they are suggested as potential biomarkers for whole grain wheat and rye intake [51, 52].
Extraction and analysis of alkylresorcinols
For analytical studies, ARs require previous extraction and
identification. The extraction process from cereal grains is
important for accurate quantification of AR content in whole
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grain food products as they are potentially phytochemicals
for use in disease prevention. Several methods including
modern technologies have been applied to the extraction
of ARs from plant material, mainly conventional solvent
extraction, ultrasonic-assisted extraction (UAE), and subcritical fluid extraction (SFE) [15]. Briefly, the conventional
extraction methods include Soxhlet extraction, stirring,
distillation, manual mixing, and percolation. The extraction methods use refluxing samples with different organic
solvents like acetone, ethylacetate, hexane, and propanolwater mixture (3:1) because ARs are insoluble or poorly
soluble in water. Extraction methods are expensive and time
consuming (1–48 h). SFE is a technique that uses a supercritical fluid as the extracting solvent and carbon dioxide
(CO2) is the most used supercritical fluid [53, 54]. The fluid
is allowed to flow at a desired pressure of 40 MPa through
a milled sample at an extracting temperature of 40–80 °C.
The CO2 fluid is often modified using ethanol or methanol
to increase the extraction yield. The major advantage of
SFE-CO2 is high selectivity which shortens extraction time
and lowers organic solvent costs compared to conventional
extraction methods. Similarly, UAE is an efficient and inexpensive modern extraction technique of increased selectivity and kinetics. In UAE extraction, ultrasound is used
to break the cell membranes. Diffusion of solvent through
membranes is accelerated, thus the release of cell contents is
facilitated [55]. It is worth noting that an important property
of compounds containing phenol group, like antioxidant
potential, may be influenced by the extraction solvent and
extraction time [56]. However, no qualitative or quantitative differences in AR extradition were found after applying
supercritical CO2 and conventional extradition using ethyl
acetate [57]. To determine the AR structure–activity relationship, synthetic compounds are prepared using Grignard
and Wittig reactions [58]. Colorimetric methods, thin-layer
chromatography, high-performance liquid chromatography,
gas chromatography, mass spectrometry, and nuclear magnetic resonance are the techniques used for ARs separation,
identification, structure establishment, and qualitative and
quantitative analysis [15, 54, 59].

Biological activity of alkylresorcinols
ARs exhibit a wide range of biological properties due to
their amphiphilic properties resulting from the presence of
polar water-soluble OH groups attached to the benzene ring
and the presence of a water-insoluble hydrocarbon chain.
Current evidence for the biological importance of ARs is
based mainly on in vitro examination. Three kinds of positive effects of whole grain cereals are identified: nutritional,
mechanistic (due mainly to the fiber content), and antioxidant (due to ARs and phenolic acids) [39, 60].
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Detections of ARs or their main metabolite concentration in blood plasma, erythrocytes, adipose tissue, and in
urine are used to estimate whole cereal intake. Several
studies reported positive correlations between whole grain
intake and the presence of ARs in plasma or their urinary
metabolites [36, 51, 61–69]. Finding of in vitro studies
have shown that ARs exhibit a broad range of bioactivities
including a high affinity to liposome and erythrocyte membranes increasing their permeability, antifungal, antimicrobial, and anticancer abilities [70–78]. ARs can potentially
affect all processes regulated by enzymes; this suggests that
ARs may exhibit anti-oxidative, anticancer, and antimutagenic activities, induction of apoptosis, and inhibition of
some enzymes activities including lipoxygenases, monoamine oxidase, tyrosinase, 
Ca2+-ATPase, α-glucosidase,
dehydrogenase, DNA polymerase β, and lipase in the adipose tissue cells. ARs may also reduce adipose triglyceride, decrease copper-induced oxidation of LDL, inhibit
DNA-strand scission, and limit nucleic and protein synthesis in thymocytes [42, 71, 72]. In vitro experiments show
an inhibition of the human 20S chymotrypsin producing
proteasome activities by several synthetic ARs and their
homologues with a high potency. This human proteasome
includes the catalytic core of a proteinase complex playing
several important functions in cells such as controlling proteins p53, p27, and cyclin B levels and the ATP-dependent
ubiquitin-mediated protein degradation [58].
Whole grains can improve insulin sensitivity due to
their low glycaemic index [49]. Biskup et al. reported
that only whole grain intake dominated by rye consumption may be important for type 2 diabetes mellitus prevention based on case-control study (931 cases, 931 controls)
[65]. Ross et al. reported ARs can regulate with the high
potency the γ-tocopherol and cholesterol concentrations
in rat livers [79]. Further, the researchers found high doses
of AR intake decreased excess hepatic lipids which can
lead to hepatic insulin resistance and type 2 diabetes and
increased concentrations of γ-tocopherol caused by slower
metabolism [80]. In turn, a large population-based intervention study reported whole grain consumption is linked
with decreased concentration of non-esterified fatty acids
in plasma [36]. Also, Söderholm et al. found decreased peroxidation of LDL in the presence of copper ions in humans
after 4 weeks of rye bread consumption [81]. Considering
the antioxidant potential of ARs, it is worth noting that this
activity is estimated at 10% of α-tocopherol antioxidant
capacity, and the hydrogen donation ability of ARs corresponds to 30% of that exhibited by ferulic acid [36, 42,
82–85].
Some reports indicate weak direct antioxidant activities of ARs due to their hydrogen atom donor and free
radical scavenging activities [60, 82, 83], but note a
strong protective action in phospolipid bilayers, such
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as inhibition of linolenic acids oxidation and protection
against H2O2-induced oxidation of erythrocytes [42]. The
weak direct antioxidant power of ARs using the ferric
reducing ability of plasma and DPPH assays was observed
by Parrika et al. [82] who reported antioxidant activities
of several ARs with chains lengths C15:0, C17:0, C19:0,
C21:0, and C23:0 using the HT29 human colon cancer cells. ARs were found to increase the self-protection
properties of these cells against DNA damage caused by
H2O2 or genotoxic fecal water samples. Parrika et al. also
observed a strong protective effect of these compounds
against the Cu ion-induced oxidation of low-density lipids.
Notably, lipid peroxidation is currently considered as the
main biochemical mechanism involved in cell damage [13,
86]. Peroxidation of lipids is a chain reaction with repetitive H abstraction by hydroxyl radical and peroxyl radical. The main target is methylene group of polyunsaturated
lipids. An addition of molecular oxygen (O2) to the alkyl
radicals resulting in generation of peroxyl radicals (ROO·)
leads to their oxidative destruction [86]. The antioxidant
property of ARs as polyphenolic compounds originates
from the ability of their hydroxyl groups to donate H to a
free radical, or to donate one electron to an alkyl free radical, which breaks the chain reaction of lipid peroxidation.
Thus, ARs may modulate cellular redox state and protect
proteins, phospholipids, DNA, RNA, and carbohydrates
against peroxidation [82, 84, 85, 87].
There are no oral dosing studies that examine pure ARs
in humans [38]. Only a few dietary clinical intervention trials have studied the effect of whole grains intake on health
[20, 88–91]. For example, in a 12-week observational
dietary intervention trial (n = 79), Kristensen et al. examined the effect of replacing refined wheat with whole grain
wheat on body weight and percent body fat [90]. The outcome suggested intake of whole grain products may cause
a greater reduction in fat mass percentage but was not associated with body weight change. Moreover, total and LDL
cholesterol in serum was found to be increased in refined
wheat consumers compared to whole grain wheat consumers (5.91 vs. 5.59 nM, p = 0.02 and 3.96 vs. 3.73 nM,
p = 0.02, respectively). In turn, Tighe et al. found that daily
intake of three portions of whole grain foods reduced cardiovascular disease in middle-aged people [89].
Prospective studies
Four observational studies [69, 92–94] were included in
analysis of the association of ARs intake with cancer risk,
among which two studies [92, 93] involved colorectal cancer. One study dealt with prostate cancer [69] and one study
[94] with endometrial cancer (Table 1). The first study
on colorectal cancer included a large, multicenter cohort
with more than one million individuals from 10 European

A nested case-control study: 1016
cases, 1817 controls

Nested case-cohort study, 177 cases, Endometrial cancer
No significant association between
152 sub-cohort members
plasma levels of individual and
The highest vs the lowest quartile of
the total sum of AR homologs and
plasma concentration of individual
endometrial cancer risk
or the total sum of AR homologs

Drake et al. [69]
Diet and Cancer Study (MDC
cohort); Malmö

Olsen et al. [94]
Danish “Diet, Cancer and Health”
prospective cohort study; Copenhagen and Aarhus area

Non-significantly increased risk
Significant correlations between
ARs metabolites in plasma and
whole grain intake.
Observed evidence of a non-linear
relation between ARs concentrations and cancer risk

No significant association between
ARs concentration in plasma and
any colorectal cancers (colon,
proximal, distal or rectum)
Increased risk for high levels of
ARs: OR = 1.41 (1.10–1.80)

Parity, menopausal status, use of HRT,
smoking status, use of estrogen,
BMI

Age, date of study entry, height, waist
circumference, education level,
smoking status, energy intake

No effect for overall colorectal
cancer, proximal colon cancer, and
rectal cancer
Decreased risk of distal colon cancer Age, sex, study center, time of blood
collection, fasting status, additionOR = 0.34 (0.13–0.92)
ally conditioned on menopausal
status, HRT use or oral contraceptives for women

IRR incidence rate ratio, OR odd ratio, CI confidence interval, M males, F females, BMI body mass index, HRT hormone replacement therapy

Low or higher vs moderate levels of
AR metabolites in plasma

Prostate cancer
The highest (median 130.3 nM)
versus moderate (median 44.1 nM)
levels of ARs metabolites in
plasma

Semi-reported food frequency questionnaires of whole grain intake

Colorectal cancer
The highest vs the lowest quartile of
plasma ARs concentrations

A nested case-control study; 522
cases, 562 controls. The median
follow-up period for cases was
4.6 years
M/F

Knudsen et al. [93] HELGA cohort

Adjustment for confounders

Decreased risk of distal colon cancer BMI, intake of red and processed
meat, PA, smoking, education,
IRR = 0.48 (0.28–0.83)
alcohol intake

Colorectal cancer
The highest vs the lowest quartile of
plasma total ARs concentrations
Semi-reported food and lifestyle
questionnaires

A nested case-control study; 1373
cases, 1373 controls in a cohort
M/F

Kyrø et al. [92]
European Prospective Investigation
into Cancer and Nutrition

Effect on cancer incidence, relative
risk (95% CI)

Type of measurement/specific cancer site/contrast

Study design, N, sex

First author, study reference

Table 1  Characteristics of studies that investigated the association of alkylresorcinols and cancer risk
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countries [92]. Total plasma concentration defined as a sum
of plasma AR homologues C17:0, C19:0, C21:0, C23:0,
and C25:0 was analyzed in matched case-control pairs.
The incidence rate ratio (IRR) of distal colon cancer was
reduced by 52% among individuals with AR concentrations
in plasma >99 nM in men and >84 nM in women (78 cases,
114 controls). Also, a 17% reduction in IRR of colon cancer was reported for Scandinavian participants (252 casecontrol pairs). The investigators noticed an inverse relationship between total plasma AR concentrations and colon and
distal colon cancer which occurred only in individuals from
areas where intake of ARs is high, stable, and frequent, i.e.,
in the Central Europe and Scandinavia.
The second study on the AR-colorectal cancer relationship examined levels of plasma AR homologues (C17:0,
C19:0, C21:0, C23:0, and C25:0) and also used the food
frequency questionnaire (FFQ) of whole grain intake [93].
The study included three cohorts: The Norwegian Women
and Cancer Study, the Northern Sweden Health and Disease Study, and the Danish Diet, Cancer, and Health Study
(a research project on Nordic health effects of whole grain
consumption, HELGA). Approximately one hundred
twenty thousand men and women aged 30–64 years experienced a 64% decreased risk of distal colon cancer (198
case–control pairs) reported after comparing the highest
quartiles (>118.6 nM for men and >91.7 nM for women)
with the lowest (≤35.3 nM for men and <27.5 nM for
women) of AR plasma concentrations. Investigators suggested that usage of both assays, i.e., plasma ARs detection
and FFQs of whole grains intake, slightly increases the precision of the study compared to a measure of the association whole grain products intake—cancer risk, using only
an FFQ as the exposure measurement. This suggestion was
based on finding no significant relationship between wholegrain intake and colorectal cancers when an FFQ was
used as an assay.
Only one observational study [69] was identified and
included in the comparative analysis between the highest
and lowest levels of plasma AR metabolite concentrations
and the risk of prostate cancer that estimated the dose–
response (Table 1). The study analyzed prostate cases from
the Swedish MDC cohort; the odds ratio among men was
1.41 (1.10–1.80) of which plasma AR metabolites concentrations ranged from 93.0 to 596.2 nM (226 cases) compared to those which plasma AR metabolites concentration ranging from 34.1 to 55.8 nM (179 cases). A slightly
higher significant risk was found for low-risk prostate cancer (46%); although the positive association between AR
metabolite concentrations and prostate cancer risk had no
linear shape. Interestingly, the positive associations of fiber
and whole grain intake with prostate cancer was found by
Nimptsch et al. in the Health Professionals Follow-up Study
(hazard ratios, HR = 1.13; 95% CI = 1.03–1.24, 49,934
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cases) which lacks statistical importance after restriction
to PSA screening [95]. Investigators also observed nonsignificant increased ORs among 647 cases with low risk
of prostate cancer and 353 cases with high risk, and for 465
cases with symptomatic prostate cancer. Further, significant
moderate correlations between AR metabolites and whole
grain products intake were found. The results from this
study led investigators to conclude high whole grain intake
does not reduce risk of prostate cancer.
A case-control study of the Danish postmenopausal
women aged between 53–60 years including 177 endometrial cancer cases and 152 sub-cohort members as a control
group evaluated concentrations of AR homologues (C17:0–
C25:0) in their plasma [94]. Median AR concentration
of 78 nM and a lack of statistically important differences
between cases and controls with regard to the AR concentration in plasma were found. Investigators confirmed that
rye bread consumption was the primary determinant of AR
levels and elevation of plasma AR concentrations in nonfasting blood samples. A group of 360 postmenopausal
Danish women had the same level of ARs for the joined
controls and endometrial cancer cases (n = 176) [62].
Cytotoxic activities of alkylresorcinols
Ten in vitro studies [58, 84, 96–103] were identified and
included in the analysis of natural and synthetic ARs
for activities that inhibit growth of human cancer cells
(Table 2). The studies focused on isolation and identification of naturally occurring ARs and their synthesis. Two
studies [58, 96] reported isolation of ARs from wheat bran,
a synthesis of several dozens of ARs and their evaluation
for growth inhibitory potential against human colon cancer
cell lines HCT-116 and HT-29, when treated with various
concentration of ARs extracted from wheat bran oil [96].
Investigators examined a series of ARs having different site
chain lengths (synthetic including those of short to moderate length side chain: C9:0, C11:0, C13:0, C15:0, C17:0
[58] and those isolated from wheat bran oil: C17:0–C25:0)
[96] (see Table 2). The inhibitory effect on the colon cell
lines growth was reported as an IC50 (the half maximal
inhibitory concentration as a measure of the activity of
AR in inhibiting cancer cell growth). The observed cytotoxic effect was dependent on chemical structure of ARs,
being weaker for the compounds with the longer alkyl site
chain (C > 17) and dependent on type of colon cancer cells
HCT-116 or HT-29, with IC50 values about 15 µM (C13:0
and C15:0) and approximately 25 µM for compounds
C:13 and C15:0, respectively [58]. ARs C13:0 and C15:0
were the most effective as colon cancer cell growth inhibitors, and hydroxyl groups in meta-position at C1 and C3
on the aromatic ring played an important role in inhibition
of cancer cell growth. Investigators also found wheat bran

Barbini et al. [84]

Liu et al. [99]

Chuang and Wu [98]

Sánchez et al. [97]

Zhu et al. [96]

Human colon cancer cell lines HT-29 and HTC-116 Fifteen synthetic ARs including five of short to
moderate length side chain (C9:0, C11:0, C13:0,
C15:0, C17:0)
Concentration range: 0–50 µM

Inhibition of cell lines by ARs having short to moderate length side chain. HT-29: I C50 values ranging
between 24.86 and >50 µM; HCT-116: IC50 values
ranging between 14.84 and 53.10 µM. Other test
ARs showed IC50 values above 100 µM
Observed the greatest inhibitory effects in both colon
cancer cells lines for ARs C13:0 and C15:0, which
decreased with increasing or decreasing the side
chain lengths
Human colon cancer cell lines HT-29 and HTC-116 Thirteen ARs from wheat bran oil: C17:0-C25:0
Inhibition of both colon cancer tumors growth:
Concentration range: 5–50 mg/L
HT-29:IC50 values ranging between 81.1 and
>108.4 µM, HTC-116:IC50 values ranging between
47.5 and >108.4 µM
Inhibition was dependent on chemical structure of
ARs; the longer alkyl side chain the weaker inhibition; the presence of a double bond and a carbonyl
group caused an increase of inhibition
Human breast (MCF-7), lung (H-460), central nerv- Five ARs isolated from the leaves of Homalomena Inhibition of all cancer tumors growth: MCF-7:IC50
ous system (SF-268) human cancer cell lines
wendlandii Schott (Araceae)
values ranging between 8.24 and >42.17 µM;
H-460:IC50 values ranging between 10.02 and
>42.17 µM; SF-268:IC50 values ranging between
14.53 and >42.17 µM
The cytotoxic effects on cancer cells of ARs were at
least 8.0, 9.5, and 13.8 times lower compared to
the positive control adriamycin, respectively
Human breast (MCF-7), lung (H-460), central nerv- Fourteen ARs compounds isolated from the leaves Inhibition of all tested cancer tumors growth: MCFous system (SF-268) human cancer lines
of Grevillea robusta as pure compounds
7:IC50 values ranging between 28.6 and 37.1 µM;
NCI-H460:IC50 values ranging between 22.8 and
35.4 µM; SF-268: I C50 values ranging between
27.7 and 39.8 µM
All examined ARs exerted the cytotoxic effect on the
Human prostate adenocarcinoma (PC3) cell line
ARs with long chain (≥C17:0) alkenyl—and
PC3 cell line. I C50 values ranging between 24.4
from the European Collection of Cell Culture
oxoalkyl—resorcinols (seven pure compounds
isolated from wheat bran)
and >531.9 µM
Concentration range: 25–200 mg/L
Four of the seven tested ARs were more active
against the cancer cell line ( IC50 values ranging
from 24.4 to 105.0 µM) compared to the positive
control chlorambucil ( IC50 = 192.9 µM)
Human hepatocarcinoma cell lines, HepG2 and
5-alkylresorcinol isolated from Lithraea molleoides Inhibition of cancer cells growth: HepG2:
Hep3B
IC50 = 45.49 µM; Hep3B: I C50 = 43.17 µM
Concentration range 1–4 mg/L
The effects on cellular morphology, such as DNA
fragmentation characteristic of apoptosis, fragmentation and condensation of nuclei have been
reported

Activity/effect

Zhu et al. [58]

Alkylresorcinols/concentration

Model system

References

Table 2  The cytotoxic activity of alkylresorcinols on cancer cell lines
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Human prostate (PC-3), colon (HCT-116), and
breast (MCF-7) cancer cell lines

Human breast cancer cell lines BT-20
Human cervical cancer cell lines HeLa

Two ARs, (3-methoxy-5-octylphenol and 3-methHuman ceruix adenocarcinoma (HeLa), cervix
squamous carcinoma (SiHa), breast cancer adeno- oxy-2-methyl-5-pentylphenol) isolated from
Bonellia macrocarpa roots
carcinoma (MCF-7), prostate adenocarcinoma
(DU-145) cell lines

Al-Mkhlafi et al. [101]

Kubo et al. [102]

Vila-Luna et al. [103]

Activity/effect

13

IC50—the 50% inhibitory concentration of AR for treated cancer cells; TGI—the concentration of the compounds that totally inhibits cell growth; L
 C50—the concentration of the compounds
that results in death to 50% of cells

Both ARs exhibited low cytotoxic activity against all
tested cancer cell lines ( IC50 (µM): HeLa—308.24,
233.83; SiHa—154.8, 107.04; MCF-7—262.56,
184.34; DU-145—195.32, 130.15 for 3-methoxy5-octylphenol and 3-methoxy-2-methyl-5-pentylphenol, respectively) as compared to docetaxel
activity (0.25, 0.22, 0.01 and 0.01, respectively).
The compounds exhibited better cytotoxic activity
than antiproliferative activity in all tested cell lines
(IC50 (µM): 577, 490; 262, 353; 356, 304; 590,
222 µM, respectively)

Ten 5-ARs isolated from the leaves of Oncostemon Inhibitory effect; I C50 values ranging between 17.89
and 22.92 µM
bojerianum A. from the uriname and Madagascar
rainforests
Several ARs isolated from leaves of Labisia pumila Compounds 1–0-methyl-6-acetoxy-5-(pentadec10Z-enyl) resorcinol and acetoxyresorcinol
(Myrsinaceae) were evaluated for cytotoxic
1–0-methyl-6-acetoxy-5-pentadecylresorcinol
activity at concentration of 10 µM against MCF-7
exhibited sub-micromolar to low micromolar
breast cancer cells. Next, the ARs causing >50%
growth inhibitory activities for the tested cancer
cell death were tested at concentrations ranging
from 0.1 to 100 µM to obtain IC50, TGI, and LC50 cell lines: I C50 values ranging from 0.3 to 0.5 µM,
TGI—from 1.0 to 15.0 µM, and L
 C50-from 7.7 to
parameters
41.3 µM. The authors observed the cancer-type
selectivity against PC-3 and HCT-116 cells at
the TGI and LC50 concentrations. TGI and L
 C50
values were lower in PC-3 and HCT-116 cells than
in MCF-7 cells indicating lower sensitivity of the
MCF-7 cells. The cytotoxic power of these two
ARs was higher than anticancer drug doxorubicin
at the I C50 level
Four cardols (5-alkylresorcinols) and four methyl- All examined cardols exhibited significant cytotoxiccardols isolated from the cashew nut and nut shell ity against both cancer cell lines. For BT-20 lines
IC50 values ranging between 5.40 and 19.51 µM.
oil
For HeLa lines IC50 values ranged between 8.15
and 12.5 µM. All tested compounds had a C15:0
alkyl side chain with up to three double bonds

Human ovarian A2780 cancer cell line

Chaturvedula et al. [100]

Alkylresorcinols/concentration

Model system

References

Table 2  continued
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oil fractions containing 5-n-alk(en)ylresorcinols exerted the
strongest inhibitory effect on the proliferation of human
colon cancer cells [96], however their ability to inhibit
colon cancer cell lines was lower than synthetic ARs.
In other research, ARs were responsible for the inhibition of human breast, lung, and central nervous system cancer cell growth [97]. The compounds cytotoxicity toward
cancer have been presented on MCF-7, H-460, and SF-268
cell lines using five isolated natural ARs. Importantly, the
isolated ARs exhibited at least an 800% stronger inhibitory effect on the tested cancer cell lines than the commonly known cytostatic adriamycin. This study confirmed
the findings of Zhu et al. [96] that free phenolic hydroxyl
groups of ARs play important role in anticancer action.
These findings confirmed also previously published evidence on an inhibitory effect of 14 ARs isolated from
leaves of a tropical ornamental tree on human breast carcinoma, lung carcinoma, and central nervous system carcinoma cells [98]. This study observed slightly lower IC50
values in the human lung tumor cell line (NCI-H460) compared to the human breast tumor and human central nervous system cancer cell lines. Investigators suggested the
comparable values of IC50, obtained during the cytotoxic
evaluation of ARs, can attest that the alkyl chain structure
(straight or cyclic) has no effect on cancer cell inhibition.
In turn, a study by Liu et al. confirmed in vitro anticancer effects of ARs using human prostate adenocarcinoma
(PC3) cells [99]. Liu et al. isolated seven pure ARs from
wheat bran and four exhibited strong inhibitory capacity against the growth of PC3 cells; the latter compounds
C17:0, C19:1, C21:1, and C23:0xo were the minor ARs
with low yield in the isolation process. In conclusion, Liu
et al. suggested their results are the first in the literature
showing the cytotoxicity of ARs with a longer chain than
C17:0 isolated from wheat bran.
Another study demonstrated the cytotoxic effect of
5-alkylresorcinol (5-AR) isolated from L. molleoides
leaves in the human hepatocarcinoma cell lines HepG2 and
Hep3B [84]. Treatment of both cell lines with 5-AR for
24 h resulted in induction apoptosis, DNA fragmentation,
and nuclear condensation. Cell death observed in both cell
lines tested included AR concentration-dependent where
IC50 values found for HepG2 and Hep3B were similar.
Investigators indicated an important property of 5-AR as of
an inductor of apoptosis independently on a p53 pathway
(p53 gene is the most commonly mutated gene in hepatocellular cancer). The ability of ARs to inhibit the growth
of ovarian cancer cells has been reported by Chaturvedula
et al. [100]. Effects of eight new 5-ARs isolated from leaves
of Myrsinaceae and two known early ARs on the A2780
mammalian ovarian cancer cell line were examined. All
compounds inhibited the growth of the cell line; the inhibitory effect was concentration-dependent, and IC50 values
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were comparable (17.89–22.92 µM). This finding suggests
the tested compounds exhibited similar activity toward the
cancer cells and, according to the researchers, the activity
depends mainly on the basic skeleton of the 5-ARs.
The ability of ARs to inhibit the growth of prostate,
colon, and breast cancer cells has been confirmed by AlMeklafi et al. [101]. Twelve isolated ARs from an important medicinal herb in Malaysia were tested and two ARs
(structurally very closely related) exhibited the most cytotoxic activity against PC-3, HCT-116, and MCF-7 human
cancer cell lines, and were more active than doxorubicin
at the IC50 level. The compounds showed cancer cell-type
selectivity against PC-3 and HCT-116 cells at concentration which totally inhibits cell growth and concentration
which results in cell death of up to 50%. Both compounds
had a substituted aromatic ring by hydroxyl, methoxyl, and
acetyl groups and C15:0 alkyl or alkenyl side chain with
one double bond. According to Al-Meklafi et al., the presence of the double bond had no effect on the compound
cytotoxic activity [101].
The studies of Sánchez et al. [97], Chuang and Wu
[98], and Al-Mekhlafi et al. [101] confirmed the findings
of Kubo et al. [102] on cytotoxicity of ARs against human
breast cancer cell lines. Kubo et al. found that ARs and
their methyl derivatives also exhibited significant cytotoxicity against human cervical cancer cell lines HeLa. Also,
a study by Vila-Luna et al. [103] observed the cytotoxic
effect of two phenolic lipids isolated from roots of B. macrocarpa against several human cancer cell lines including cervix (HeLa, SiHa), breast (MCF-7), and prostate
(DU-145).

Discussion
This review article focuses on a relatively new research area
because AR benefits have attracted significant interest in
the last two decades. Evidence from different model studies show ARs are phenolic lipids abundant in several plant
families, some bacteria, fungi, algae, and marine sponge,
mainly as homologues with alkyl chains (C15:0–C25:0),
though many studies examined derivatives having unsaturated and oxygenated side chains. Dietary ARs are easily
absorbed by humans and several studies focused on their
detection in blood plasma, adipose tissue, erythrocytes, and
their metabolites in urine. Evidence has demonstrated that
AR content or their metabolites in humans is proportional
to intake of food products containing whole grains. Thus,
there is rich evidence on usefulness of plasma and urine
AR metabolite measurements as biomarkers of whole grain
food, mainly whole grain wheat and rye consumption [37,
38, 42, 46, 47, 49, 62, 65, 67]. Studies which analyzed AR
occurrence, absorption, metabolism, and excretion reported
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their presence at micromolar concentration in plasma being
the highest after cereal grain intake and at nanomolar concentrations at fasting conditions. All studies confirmed that
a refining process leaves only trace amounts of ARs in food
products. Phenolic compounds like ARs can potentially
affect a number of physiological and pathological processes related to metabolism and immune system functions
[71, 72, 104–111].
Results of model studies indicated that ARs which can
affect all cellular processes regulated by enzymes, affect
genotoxicity, suppress an adipocyte lipolisis, have a high
affinity to erythrocyte membranes, exert indirect antioxidant activity, and have cytotoxic effects on cancer cell
lines [58, 80, 82, 96–99, 103, 105, 112, 113]. Evidence
for AR bioactivity in vivo is limited to a few dietary clinical intervention trials which examined the effect of whole
grains intake [88–90, 114]. The majority of studies highlight cereal grains as an important source of many other
bioactive compounds, such as benzoxazinoids, lingnans,
phenolic acids, tocols, and phytosterols that are known to
reduce cancer in humans, as recently reviewed [1, 15, 19,
37, 73, 74, 114–116].
Results based on two case-control studies of lower distal colon cancer risk with high plasma AR concentrations
(Table 1) are consistent with a meta-analysis of six prospective and nested case-control studies which reported the
reduced summary relative risk of colorectal cancer after
three servings daily of whole grains (RR = 0.83) [5]. Also
noteworthy, the latest systematic review of 12 studies on
cancer mortality with 34,797 deaths related to whole grain
intake (3 studies) or whole grains product intake (9 studies) found a dose-dependent reduced risk of cancer mortality (RR = 0.82) [107]. Analysis showed that men with high
concentrations of AR metabolites in plasma had increased
prostate cancer risk. In turn, a lack of risk reduction was
observed in case of endometrial cancer. These findings are
consistent with evidence from in vitro studies with regard
to colon cancer but not prostate cancer (Table 2). In vitro
evidence showed inhibition of colon, breast, lung, and central nervous system human cancer cell growth, and the ARs
cytotoxicity against the prostate adenocarcinoma, hepatocarcinoma, cervix adenocarcinoma, cervix squamous
carcinoma, and ovarian cancer cell lines. We noticed that
the chain length of ARs was important for the ARs ability
to inhibit cancer growth, with shorter chains like C13:0,
C15:0, and C17:0 appearing to have the highest potency
of cancer inhibition which is in line with previous findings [105]. Long chain ARs may be absorbed to a lesser
extent compared to the shorter-chain homologs. The listed
IC50 values in Table 2 allow us to suggest high levels of
ARs appeared to be toxic to cancer cells. These findings
are consistent with evidence from the model studies which
reported a lack toxicity of ARs of moderate concentration,
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i.e., of 5–20 µM toward to healthy HepG2 or 3T3-L1 cells
[42, 107, 113].
The observed differences between findings reported in
Tables 1 and 2 may be explained by a relative short half-life
time (~4–5 h) limiting the precision of plasma AR concentration detection, especially in populations in which food
rich in rye and whole grain components is not consumed
daily [93], although Landberg et al. reported a high correlation coefficient between plasma AR concentration and
whole grain wheat and rye intake during a 6-week intervention study [35]. There are several hypothesized mechanisms
by which ARs can exert inhibition of cancer risk, although
the mechanisms do not consider the possible interaction
and synergy between the functional components of a diet,
like phenolic compounds, fiber, lignans, phytosterols, and
vitamins, which are reported to exhibit beneficial effects on
human health including cancer prevention [15, 23, 37, 46].
These potential interactions need to be verified with further
research.
In vitro studies revealed the dose–response cytotoxicity
of ARs toward many cancer cell lines is due to their strong
effect on cellular morphology, such as DNA fragmentation
and nuclear condensation, among others; this action can
lead to apoptosis [84]. Increase in p53 concentration plays
a key role in the expression of pro-apoptotic proteins [104].
The apoptotic pathway has been confirmed by Barbini
et al. who observed an induction of apoptosis by 5AR in
HepG2 and Hep3B cells [84]. The group further underlined an important feature of 5-AR for hepatocellular carcinoma therapy, i.e., its ability to trigger apoptosis independently on p53 or Fas phenotypic profile as they observed in
Hep3B cells. Also, other research groups have maintained
the anticancer effects of ARs are explained by enhancing
apoptosis in genotoxically damaged lymphocytes [72].
Some studies provide insight to the ARs structure-dependent relationship finding an important role of free hydroxyl,
methoxyl, acetyl, or methyl groups on benzene rings for
observed cytotoxicity [98, 102, 103]. For example, the
comparable IC50 values observed in cytotoxicity of 14 pure
5-ARs by Chuang and Wu [98] were partially explained
by their antioxidant properties due to scavenging reactive
oxygen species and/or inhibition of enzymes involved in
the formation of free radicals under physiological conditions [70]. Alkylresorcinols contain two hydroxyl groups
placed in meta-position of the phenolic ring, thus they
have a week direct antioxidant potency. However, under
alkaline conditions and in the presence of transition metal
ions, e.g., Cu and Fe, ARs may be converted to trihydroxyalkylbenzenes—the compounds of a high antioxidant activity able to produce superoxide anion radicals and further
hydrogen peroxide and hydroxyl radicals which can damage DNA, proteins, and lipids [72, 106, 108]. Moreover, the
next important reported property of ARs that may also be
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clinically significant is a slower metabolism of these compounds under pathological conditions [67].
Results from this study agree with findings of RCTs
which demonstrated that participants receiving whole
grain interventions had reduced fasting concentrations of
insulin and glucose and reduced levels of total and LDL
cholesterols, among other potential benefits which can be
important for reduction of inflammation and certain cancers protection, as reviewed by Ye et al. [78]. The evidence
for the potential role of whole grain food intake for general health benefits and mortality prevention [107] recommends increased consumption of whole grain cereal food
products in most countries [117–119]. According to an
expert panel report on dietary recommendations [120], at
least 8 g of whole grains per about 30 g, without a fiber,
(or at least 51% of total weight as whole grain content) is
required as a minimum content of whole grains food. The
recommended quantities of daily whole grain cereal product consumption vary considerably between countries
[7, 120]. For example, at least three servings per day, i.e.,
approximately 48 g per day of whole grain cereals, are recommended in USA; three to eight servings per day of grain
products at least one-half of them contain whole grains in
Canada, at least 50 g per day of coarse grains including
whole grains in China [120]. In the Scandinavian countries, at least 75 g of whole grain cereals intake per 10 MJ
of total energy intake is recommended [40]. Of note, the
reported dietary whole grains guidelines are much higher
than their average daily consumption (e.g., 42 g per day in
Sweden, 36 g per day in Denmark). A study by Piironen
et al. reported the beneficial influence of whole grains may
result from the combined action of fiber, vitamins, phenolic
acid, ARs, micronutrients, and other phytochemicals [121].
This suggestion originates from observations that no single
antioxidant can replace natural phytochemicals in preventing disease [122]. According to Fardet, there is agreement
that the protective effect of whole grain cereals results
from the synergistic action of phytochemicals and micronutrients occurring mainly in the bran and germ fractions
[7]. To our knowledge, the synergy between phytochemicals present in whole grain cereal products is still not confirmed, due to their huge number and numerous biological
functions. However, the evidence on an association of the
whole grains consumption and decreased cancer risk is still
inconclusive.
Limitations of the study
When assessing the relationship between AR concentrations and cancer risk, several methodological issues need to
be considered. Two of the four analyzed observational studies used semi-reported food frequency questionnaires to
assess whole grains intake which is prone to measurement
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errors in evaluation of associations between dietary intake
and risk of civilization diseases [35, 117, 119, 123]. The
errors originate from a positive difference between studies in distinct definition of whole grains, a lack of full food
composition, large differences of AR concentrations in
whole grain products, variation in AR concentration with
time or a dependence of a half-time on the chain length,
and variability across studies of serving size. Next, not all
observational studies included a list of potential confounders, such as physical activity, fruits, vegetables or red meat
intake, ethnicity, and family history of cancer. These variables, which are lacking in the statistical models, might lead
to under- or over-estimation of the AR intake/cancer relationship [4, 6, 112, 124–129]. For example, physical activity is considered as an important lifestyle component, of
which the association with colorectal cancer risk has been
established as conclusive, and with the postmenopausal
breast cancer as probable [127, 130]. Moreover, a higher
intake of whole grains is usually reported by individuals of
healthier lifestyle behaviors, thus all components of lifestyle should be included in statistical analyses as important
confounders. Also, some limitations should be acknowledged when interpreting the findings from in vitro studies.
The assessment of AR cytotoxicity toward human cancer
cell lines may be underestimated because phenolic lipid
content and antioxidant activity of plant extracts largely
depend on extraction conditions and solvent polarity [56].
Due to fermentation processes, the release of ARs in vivo
may be more effective than under in vitro conditions. Furthermore, bioactivity of isolated or synthesized ARs can
decline during isolation and storage undergoing oxidation.
Also, different methods of processing influence AR concentration in a food. Plasma concentrations of ARs are also
influenced by differences in individual absorption and/or
metabolism rates. Next, the association of ARs with cancer may by dependent on embryologic origins, on kinds of
cancer or subtypes, as seen in observational findings with
colorectal cancer (Table 1). Moreover, different sensitivity levels for detection of ARs in biological samples might
introduce measurement errors which could explain relatively low AR concentrations in plasma. Finally, misclassification of an outcome when FFQs are used is also probable
because ARs are considered in the literature as biomarkers
of whole grain wheat and rye intake, only [92]. A correction for measurement errors can enhance the reported associations and weaken the discrepancy between the findings
of observational and in vitro studies.

Conclusions
This systematic review demonstrated a renewed interest
in the beneficial effect of ARs on human health. Evidence
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indicates that ARs exhibit a variety of bioactivities; they
can affect many physiological and pathological processes
related to the immune system, being involved in cell
signaling and gene regulation. These findings originate
mainly from model and epidemiological studies where
assessment of the AR bioactivity in vivo is limited to a
few dietary clinical intervention trials. ARs characteristic feature is their potential as biomarkers of whole grain
wheat and rye product consumption. There is evidence
that individuals with high plasma AR concentrations had
above 52% reduced risk of distal colon cancer with linear dependence originating from biomarker concentration and indirectly from whole grain intake. These findings show that the accuracy of epidemiological studies of
whole grain intake and cancer risk based on FFQs may
by increased by detection of AR concentration in plasma.
In vitro studies show that high-concentration ARs are
considered highly cytotoxic agents for certain types of
cancer, reporting inhibition of human colon, breast, lung,
central nervous, ovarian, cervical, and prostate tumors,
and hepatocarcinoma cancer cell lines. Furthermore, the
phenolic ring and alkyl chain are important for inhibition
of human cancer cells proliferation. This is no common
consensus or clarity on the toxicity mechanism toward
cancer cells due to multiple AR targets and the complexity of interrelations between various biochemical
actions. Observational studies help to evaluate relationships between AR intake and beneficial health effects yet
cannot be used to establish causality when compared to
intervention studies. The research literature has generated
several hypothesized molecular mechanisms of action
for ARs in the prevention of cancer and their cytotoxic
activities which include the ability to affect all cellular processes regulated by enzymes, suppress an adipocyte lipolysis, affect genotoxicity, have a high affinity to
erythrocyte membranes, and exert indirect antioxidant
capacity.
Our findings provide further support for public health
recommendations emphasizing diets rich in whole grains
as potentially preventive against some types of cancer.
The updated evidence suggests future studies should
focus on identification of a fraction from grain cereals
containing concentrations of ARs exerting the strongest
cytotoxic effect on cancer cells; this may offer new clues
to prevent cancer.
Compliance with ethical standards
Conflict of interest The authors declare no conflict of interest.
Compliance with ethics requirements This article does not contain
any studies with human or animal subjects.

13

Eur Food Res Technol (2017) 243:1693–1710
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a
link to the Creative Commons license, and indicate if changes were
made.

References
1. Sirotkin AV, Harrath AH (2014) Phytoestrogens and their
effects. Eur J Pharmacol 741:230–236
2. World Cancer Research Fund/American Institute for Cancer
Research (2007) Food, nutrition, physical activity, and the
prevention of cancer: a global perspective. Washington DC:
AICR, pp 80–116
3. Divisi D, Di Tommaso S, Salvemini S, Garramone M, Crisci
R (2006) Diet and cancer. Acta Biomed 77:118–123
4. Key TJ, Allen NE, Spencer EA, Travis RC (2002) The effect
of diet on risk of cancer. Lancet 360:861–868
5. Aune D, Chan DSM, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Dietary fibre, whole grains, and risk of
colorectal cancer: systematic review and dose–response metaanalysis of prospective studies. BMJ 343:d6617
6. Baena R, Salinas P (2015) Diet and colorectal cancer. Mauritas 80:258–264
7. Fardet A (2010) New hypotheses for the health-protective
mechanisms of whole-grain cereals: what is beyond fibre?
Nutr Res Rev 23:65–134
8. Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem
Farmacol 71:1397–1421
9. Androutsopoulos VP, Papakyriakoub A, Vourloumisb D, Tsatsakisa AM, Spandidosc DA (2010) Dietary flavonoids in cancer
therapy and prevention: substrates and inhibitors of cytochrome
P450 CYP1 enzymes. Pharmacol Therapeut 126:9–20
10. Govind P (2011) Antioxidant vegetables act against cancer
and other diseases. IJPSR II:32–38
11. Zhang X, Yeung ED, Wang J, Panzhinsky EE, Tong C, Li W
(2010) Isoliquiritigenin, a natural anti-oxidant, selectively
inhibits the proliferation of prostate cancer cells. Clin Exp
Pharmacol Physiol 37:841–847
12. Liou GY, Storz P (2010) Reactive oxygen species in cancer.
Free Radic Res 44:479–496
13. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidant in normal physiological function and human disease. Int J Biochem Cel Biol
39:44–84
14. Romaneiro S, Pareki N (2012) Dietary fiber intake and colorectal cancer risk. Top Clin Nutr 27(1):41–47
15. Luthria DL, Lu Y, John KM (2015) Bioactive phytochemicals in wheat: extraction, analysis, processing, and functional
properties. J Funct Foods 18:910–925
16. Reiss J (1989) Influence of alkylresorcinols from rye and
related compounds on the growths of food-borne mould.
Cereal Chem 66:491–493
17. Iwatsuki K, Akihisa T, Tokuda H, Ukiya M, Higashihara H,
Mukainaka T, Iizuka M, Hayashi Y, Kimura Y, Nishino H (2003)
Sterol ferulates, sterols, and 5-alk(en)ylresorcinols from wheat,
rye, and corn bran oils and their inhibitory effects on Epstein–
Barr virus activation. J Agric Food Chem 51:6683–6688
18. Hladyszowski J, Zubik L, Kozubek A (1998) Quantum mechanical and experimental oxidation studies of pentadecylresorcinol,
olivetol, orcinol and resorcinol. Free Radic Res 28:359–368

Eur Food Res Technol (2017) 243:1693–1710
19. Hallmans G, Zhang JX, Lundin E, Stattin P, Johansson A,
Johansson L, Hulten K, Winkvist A, Lenner P, Aman P, Adlercreutz H (2003) Rye, lignans and human health. Proc Nutr
Soc 62:193–199
20. Chanson-Rolle A, Meynier A, Aubin F, Lappi J, Poutanen K,
Vinoy S, Braesco V (2015) Systematic review and meta-analysis of human studies to support a quantitative recommendation for whole grain intake in relation to type 2 diabetes. PLoS
One 10(6):e0131377. doi:10.1371/journal.pone.0131377
21. Shahidi F, Chandrasekara A (2013) Millet grain phenolics and
their role in disease risk reduction and health promotion: a
review. J Funct Food 5:570–581
22. Seo CR, Yi B, Oh S, Kwon SM, Kim S, Song NJ, Cho JY,
Park KM, Ahn JY, Hong JW, Kim MJ, Lee J, Par KW (2015)
Aqueous extracts of hulled barley containing coumaric acid
and ferulic acid inhibit adipogenesis in vitro and obesity
in vivo. J Funct Food 12:208–218
23. Sang S, Zhu Y (2014) Bioactive phytochemicals in wheat bran
for colon cancer prevention. In: Watson RR, Predy V, Zibadi
S (eds) Wheat and rice in disease prevention and health: benefits, risks and mechanisms of whole grains in health promotion. Academic Press, Waltham, MA, pp 121–129
24. Andersson U, Dey ES, Holm C, Degerman E (2011) Rye bran
alkylresorcinols suppress adipocyte lipolysis and hormone-sensitive lipase activity. Mol Nutr Food Res 55(Suppl 2):290–293
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